Intelligent Bio Solutions Inc. (INBS)

USD 1.28

(4.51%)

Net Debt Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual net debt in 2024 was -5.43 Million USD , down -2595.32% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly net debt in 2024 FY was -5.43 Million USD , down -2595.32% from previous quarter.
  • Intelligent Bio Solutions Inc. reported annual net debt of -201.55 Thousand USD in 2023, up 97.55% from previous year.
  • Intelligent Bio Solutions Inc. reported annual net debt of -8.23 Million USD in 2022, up 34.48% from previous year.
  • Intelligent Bio Solutions Inc. reported quarterly net debt of -8.46 Million USD for 2024 Q3, down -22150.97% from previous quarter.
  • Intelligent Bio Solutions Inc. reported quarterly net debt of -5.43 Million USD for 2024 FY, down -2595.32% from previous quarter.

Annual Net Debt Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Net Debt of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Net Debt Net Debt Growth
2024 -5.43 Million USD -2595.32%
2023 -201.55 Thousand USD 97.55%
2022 -8.23 Million USD 34.48%
2021 -12.57 Million USD -367.16%
2020 4.7 Million USD -4.6%
2019 4.93 Million USD 11.58%
2018 4.42 Million USD 27.12%
2017 3.47 Million USD 0.0%

Peer Net Debt Comparison of Intelligent Bio Solutions Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD 86.23%
Applied DNA Sciences, Inc. -5.91 Million USD 8.14%
Aspira Women's Health Inc. -331 Thousand USD -1541.286%
Biodesix, Inc. 34.3 Million USD 115.835%
BioNexus Gene Lab Corp. -5.79 Million USD 6.268%
bioAffinity Technologies, Inc. -1.24 Million USD -337.084%
bioAffinity Technologies, Inc. -1.24 Million USD -337.084%
Bionano Genomics, Inc. 34.88 Million USD 115.574%
CareDx, Inc -47.97 Million USD 88.676%
Check-Cap Ltd. -24.75 Million USD 78.055%
Castle Biosciences, Inc. -83.53 Million USD 93.496%
DarioHealth Corp. -7.54 Million USD 28.025%
Exact Sciences Corporation 1.94 Billion USD 100.279%
Fulgent Genetics, Inc. -82.56 Million USD 93.42%
Guardant Health, Inc. 220.22 Million USD 102.467%
ICON Public Limited Company 3.56 Billion USD 100.153%
IDEXX Laboratories, Inc. 493.94 Million USD 101.1%
Illumina, Inc. 1.21 Billion USD 100.448%
iSpecimen Inc. -2.14 Million USD -152.985%
Standard BioTools Inc. 46.5 Million USD 111.682%
MDxHealth SA 18.88 Million USD 128.767%
23andMe Holding Co. -141.37 Million USD 96.157%
Medpace Holdings, Inc. -103.32 Million USD 94.742%
Myriad Genetics, Inc. 88.1 Million USD 106.166%
Mainz Biomed B.V. 349.85 Thousand USD 1652.831%
ENDRA Life Sciences Inc. -2.43 Million USD -122.695%
NeoGenomics, Inc. 269.19 Million USD 102.018%
Neogen Corporation 735.62 Million USD 100.739%
Inotiv, Inc. 382.14 Million USD 101.422%
Natera, Inc. -200.1 Million USD 97.285%
OpGen, Inc. 11.89 Million USD 145.684%
OPKO Health, Inc. 230.68 Million USD 102.355%
Psychemedics Corporation 334 Thousand USD 1726.544%
Prenetics Global Limited -43.33 Million USD 87.464%
Prenetics Global Limited -43.33 Million USD 87.464%
Precipio, Inc. -386 Thousand USD -1307.424%
Personalis, Inc. -8.02 Million USD 32.278%
RadNet, Inc. 1.14 Billion USD 100.473%
Sera Prognostics, Inc. -2.02 Million USD -168.677%
Sotera Health Company 2.02 Billion USD 100.268%
Neuronetics, Inc. 2.79 Million USD 294.232%
Star Equity Holdings, Inc. -15.33 Million USD 64.578%
Star Equity Holdings, Inc. -15.33 Million USD 64.578%
Trinity Biotech plc 63.73 Million USD 108.524%
T2 Biosystems, Inc. 33.8 Million USD 116.069%
Twist Bioscience Corporation -192.4 Million USD 97.176%
Exagen Inc. -12.77 Million USD 57.464%